Pediatric allergy and respiratory disease (소아알레르기 및 호흡기학회지)

The Korean Academy of Pediatric Allergy and Respiratory Diseasse (대한소아알레르기호흡기학회)
권호 표지

Functions of Siglecs in Allergic Inflammation

알레르기 염증반응에서 Siglecs의 기능

이현희

  • Published : 20060000
⟨ Previous Next ⟩

Abstract

Siglecs are sialic acid binding Ig-like lectins, subset of the immunoglobulin superfamily. They are characterized by a homologous N-terminal V-set Ig-like domain and C2 set Ig- like domains. N-terminal domains have sialic acid binding activity. In humans, 11 Siglecs have been described sialoadhesin(Siglec-1), CD22(Siglec-2), CD33(Siglec-3), MAG(Siglec-4), more recently described CD33-related Siglecs(Siglec 5-11). Siglecs express most signal via immunoreceptor tyrosine-based inhibition motif(ITIM) cytoplasmic domains. The cytoplasmic tails of all Siglecs except sialoadhesin have one or more tyrosine residues within potential signaling motifs. Inhibitory function of other Siglecs such as Siglec-7 or Siglec-9 was shown in RBL-2H3 cells. Co-crosslinking of Siglec-7 or Siglec-9 and FcεR1 substantially reduced the serotonin release of RBL-7 and RBL-9 cells. Siglec-8 is expressed on human eosinophils, mast cells and basophils. Siglec-8 has two tyrosine motifs, a proximal motif and a distal motif. They have some inhibitory functions in immune system. We have observed that Siglec-8 is able to inhibit the IgE receptor-mediated β-hexosaminidase release of RBL-2H3 cells following co-crosslinking. Co-crosslinking of Siglec-8 and FcεR1 reduced the hexosaminidase release of RBL-2H3 cells. These results show that Siglec-8 is as potent as Siglec-7 and Siglec-9 in delivering inhibitory signals to RBL-2H3 cells. Siglec-8 should be a new member of the inhibitory receptor superfamily and the membrane-proximal ITIM is essential for the inhibitory function of Siglec-8 molecules. Although these molecules present specific marker for the allergic cell types, more work is needed to understand the signaling mechanism and the role in various disease processes.

Keywords

References

  1. Crocker PR, Mucklow S, Bouckson V, Mc-William A, Willis AC, Gordon S. Sialoadhesin, a macrophage sialic acid binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO J 1994;13:4490-503
  2. Crocker PR, Clark EA, Filbin M, Gordon S, Jones Y, Kehrl JH, et al. Siglecs : a family of sialic acid binding lectins. Glycobiology 1998;8:v
  3. Stamenkovic I, Seed B. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature 1990;345:74-7 https://doi.org/10.1038/345074a0
  4. Powell LD, Varki A. I-type lectins. J Biol Chem 1995;270:14243-6 https://doi.org/10.1074/jbc.270.24.14243
  5. Crocker PR, Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol 2001;22:337-42 https://doi.org/10.1016/S1471-4906(01)01930-5
  6. Crocker PR, Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol 2002;12:609-15 https://doi.org/10.1016/S0959-440X(02)00375-5
  7. Arquint M, Roder J, Chia LS, Down J, Wilkinson D, Bayley H, et al. Molecular cloning and primary structure of myelinassociated glycoprotein. Proc Natl Acad Sci USA 1987;84:600-4 https://doi.org/10.1073/pnas.84.2.600
  8. Angata T, Hingorani R, Varki NM, Varki A. Cloning and characterization of a novel mouse Siglec, mSiglec-F : differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J Biol Chem 2001;276:45128-36 https://doi.org/10.1074/jbc.M108573200
  9. Floyd H, Ni J, Cornish AL, Zeng Z, Liu D, Carter KC, et al. Siglec-8. A novel eosinophil specific member of the immunoglobulin superfamily. J Biol Chem 2000;275:861-6 https://doi.org/10.1074/jbc.275.2.861
  10. Kikly KK, Bochner BS, Freeman SD, Tan KB, Gallagher KT, D'alessio KJ, et al. Identification of SAF-2, a novel Siglec expressed on eosinophils, mast cells and basophils. J Allergy Clin Immunol 2000;105:1093-100 https://doi.org/10.1067/mai.2000.107127
  11. Zhang JQ, Nicoll G, Jones C, Crocker PR. Siglec-9, a novel sialic-acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J Biol Chem 2000;275:22121-6 https://doi.org/10.1074/jbc.M002788200
  12. Cornish AL, Freeman S, Forbes G, Ni J, Zhang M, Cepeda M, et al. Characterization of Siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 1998;92:2123-32
  13. Nicoll G, Liu P, Klenerman J, Munday S, Dubock M, G Mattei, Crocker PR. Identification and characterization of a novel Siglec, Siglec-7, expressed by human natural killer cells and monocytes. J Biol Chem 1999;274:34089-95 https://doi.org/10.1074/jbc.274.48.34089
  14. Munday J, Kerr S, Ni J. Identification, characterization and leukocyte expression of Siglec-10, a novel human sialic acid binding receptor. Biochem J 2001;355:489-97 https://doi.org/10.1042/0264-6021:3550489
  15. Angata T, Varki A. Cloning, characterization, and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of Siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J Biol Chem 2000;275:22127-35 https://doi.org/10.1074/jbc.M002775200
  16. Vitale C, Romagnani C, Falco M, Ponte M, Vitale M, Moretta A. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc Natl Acad Sci USA 1999;96:15091-6 https://doi.org/10.1073/pnas.96.26.15091
  17. Ulyanova T, Shah DD, Thomas ML. Molecular cloning of MIS, a myeloid inhibitory Siglec that binds tyrosine phosphatases SHP-1 and SHP-2. J Biol Chem 2001;276:14451-8 https://doi.org/10.1074/jbc.M011650200
  18. Paul SP, Taylor LS, Stansbury EK, McVicar DW. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 2000;96:483-90
  19. Ulyanova T, Blasioli J, Woodford-Thomas TA, Thomas ML. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur J Immunol 1999;29:3440-9 https://doi.org/10.1002/(SICI)1521-4141(199911)29:11<3440::AID-IMMU3440>3.0.CO;2-C
  20. Falco M, Biassoni R, Bottino C, Vitale M, Sivori S, Augugliaro R. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med 1999;190:793-802 https://doi.org/10.1084/jem.190.6.793
  21. Ferlazzo G, Spaggiari GM, Semino C, Melioli G, Moretta L. Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34＋ myeloid precursors. Eur J Immunol 2000;30:827-33 https://doi.org/10.1002/1521-4141(200003)30:3<827::AID-IMMU827>3.0.CO;2-1
  22. Avril T, Floyd H, Lopez F, Vivier E, Crocker PR. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglec-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J Immunol 2004;173:6841-9 https://doi.org/10.4049/jimmunol.173.11.6841
  23. Blery M, Delon J, Trautmann A, Cambiaggi A, Olcese L, Biassoni R. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J Biol Chem 1997;272:898-9
  24. Foussias G, Yousef GM, Diamandis EP. Molecular characterization of a Siglec-8 variant containing cytoplasmic tyrosine-based motifs, and mapping of the Siglec-8 gene. Biochem Biophys Res Commun. 2000;278:775-81 https://doi.org/10.1006/bbrc.2000.3866
  25. Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol 1994;12:295-335 https://doi.org/10.1146/annurev.iy.12.040194.001455
  26. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001;344:350-62 https://doi.org/10.1056/NEJM200102013440507
  27. Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev 2001;179:163-72 https://doi.org/10.1034/j.1600-065X.2001.790116.x
  28. Nutku E, Aizawa H, Hudson SA, Bochner BS. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 2003;101:5014-20 https://doi.org/10.1182/blood-2002-10-3058
  29. Nicoll G, Avril T, Lock K, Furukawa K, Bovin N, Crocker PR. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via Siglec-7-dependent and -independent mechanisms. Eur J Immunol 2003;33:1642-8 https://doi.org/10.1002/eji.200323693
  30. Vivier E, Daeron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997;18:286-91
  31. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-93 https://doi.org/10.1146/annurev.immunol.16.1.359
  32. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904 https://doi.org/10.1146/annurev.immunol.17.1.875